SQI Diagnostics Inc SQIDF

It's time to monetize something...

[mercedesman]

$ 36M USD Market Cap?

For:

• revolutionary transplant assist technology (in partneship with the UHN, a world-leader in lung transplantation)
• Rali-Dx (as an ICU Triage tool to predict adverse inflammatory reactions to various infections inclusding Covid-19)
• perhaps the highest level of accuracy in serum based Covid Antibody testing
• Home Diagnostics for other hard to diagnose afflictions (RA, Celiac)
• Efficient/cost saving multi-plexing technology / equipment for the BioTech Industry
• PCR and asymptomatic Covid testing equipment - all rapid turn-around (jump started by recent merger - in critical industries like mining and film production)
• Surface detection technology (in partnership with McMaster U)

IMO, any one of the peices could be sold for multiples of the current MC. Collectively, likely > $ 1B USD, if properly packaged and negotiated.

Let's get'r started and get'r done.

MM

[mercedesman]

Now $ 24M USD Market Cap !? Shouldn't Rali-Dx be done by now? A much needed ICU tool !  Especailly with what is forecasted to be a nasty Flu Season (see Australia)  and with the next late fall/winter Covid-19 wave - upon us (see Europe)

[mercedesman]

Maybe they have finally figured it out ! Jack-of-all-trades, master of none. Sounds like they have picked out the golden goose from the gaggle.  Now it's time to focus...to push the "partners" to step it up (before they all go backwards together)...and to get'r done. Organ harvesting and organ tansplants are a BIG BUSINESS in the US (and a big hospital money maker) and